CKCarolina Paula Jesus Kasa

Carolina Paula Jesus Kasa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolina Paula Jesus Kasa has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analgesic Effectiveness by Pain Intensity and Location in Pediatric Oncology Patients

    by Flavia Carvalho Marotta, Eduardo Ladeia Leal, Isabelle Alvarenga Oliveira, Thuane Sales Gonçalves, Silmara Rodrigues Machado, Carolina Paula Jesus Kasa, Paulo Caleb Junior Lima Santos

    Background: Cancer in children and adolescents (ages 0 to 19) is frequently associated with pain, which is one of the most common and distressing symptoms reported by pa-tients. Effective pain management remains a major concern for healthcare teams. Despite the existence of national and international pain management protocols since the mid-1980s, challenges persist in the assessment, treatment, and follow-up of pediatric pa-tients. There is a lack of studies evaluating the most appropriate type and dosage of anal-gesics to achieve adequate pain control in pediatric oncology settings. Objective: To assess the effectiveness of selected analgesics based on pain intensity and anatomical location in pediatric cancer patients. Methods: This is a pharmacoepidemiologic study carried out in a pediatric oncology hospital, with inclusion of patients aged 0 to 17 years old with cancer and using analgesic drug. Information regarding cancer diagnosis, hospitalization diag-nosis, analgesic scale and pain intensity before and after drug administration and pain site were collected from medical records. Results: A total of 1,465 episodes of pain from 335 patients were included, most of them diagnosed with leukemia (30.1%). We included 576 episodes of pain treated with dipyrone or morphine that occurred in the abdomen (n=283), head (n=155) and lower limbs (n=138). The final pain scores indicated pharmacological effectiveness in all patient subgroups. When pain was wild to moderate, dipyrone was the most used drug: 105 (65.2%) episodes of pain that occurred in the abdomen, 93 (86.9%) in the head and 50 (64.1%) in the lower limbs. However, when the pain was severe to un-bearable, morphine was the most used drug: 79 (64.7%) in the abdomen and 36 (60.6%) in the lower limbs; except in the head (17 episodes of pain, 35.4%). Conclusions: The use of dipyrone and morphine, guided by pain intensities and locations, demonstrated effective-ness. These findings support the tailored use of analgesics according to pain characteris-tics to optimize symptom control in pediatric oncology patients.

  • Open Access

    Evaluations of NSAIDs and Opioids as Analgesics in Pediatric Oncology

    by Eduardo Ladeia Leal, Paulo Caleb Júnior Lima Santos, Thuane Sales Gonçalves, Mariana Martins Gonzaga Do Nascimento, Fábio Cardoso Cruz, Flávia Borelli Gomes Do Nascimento, Carolina Paula Jesus Kasa

    As one of the leading causes of death in childhood, cancer also causes discomfort to pediatric patients. Even with guidelines for pain management, more than half of hospitalized children have intense and unrelieved pain. The present work aims to describe the intensity of pain and its pharmacological management in a pediatric oncology population. Patients aged 0 to 17 years old, diagnosed with cancer, who were admitted to a children’s oncology hospital and had well-documented data on pain management in their medical records were included. A total of 333 patients were included, mostly male (55.8%) with a mean age of 7.9 years. A substantial portion of the patient cohort (51.4%) initially reported experiencing pain of moderate intensity during the first assessment. Subsequently, following the pharmacological intervention, a significant proportion of patients (90.1%) reported complete alleviation of pain. The predominant pharmaceutical agents utilized for pain management encompassed metamizole (76.6%) and morphine (10.2%). All pharmacological interventions used were able to significantly reduce patients’ pain. This study underscores the utilization of different pharmacological classes to achieve notable reductions in pain intensity among patients grappling with severe pain.